Inozyme Pharma to Participate in the Piper Sandler 36th Annual Healthcare Conference
Inozyme Pharma is a pioneering clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for rare diseases that affect bone health and blood vessel function. We are experts in the PPi-Adenosine Pathway,
Immuneering to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced that management will present at the Piper Sandler 36 th Annual Healthcare Conference,
U.S. Treasury yields are inching higher after Monday’s drop, as investors navigate the holiday-shortened trading week. But ...
On Wednesday, Berry Corporation (Bry) (BRY) stock saw a modest uptick, ending the day at $3.93 which represents a slight increase of $0.01 or 0.26% from the prior close of $3.92. The stock opened at ...
DeKalb County’s incoming chief executive said four outside companies will help her evaluate how well the county is operating.
The FTSE 100 consumer goods giant has hired Piper Sandler, the investment bank, to oversee an auction of the plant-based food ...
On Wednesday, Humacyte Inc (HUMA) stock saw a decline, ending the day at $4.4 which represents a decrease of $-0.03 or -0.68% from the prior close of $4.43. The stock opened at $4.44 and touched a low ...
News and Analyst Ratings. In this article, we are going to take a look at where AppLovin Corporation (NASDAQ:APP) stands ...
Piper Sandler analyst Edward Tenthoff reiterates Moderna (NASDAQ:MRNA) with a Overweight and lowers the price target from $115 to $69.
Investing.com -- Piper Sandler on Friday downgraded the residential solar company Sunrun Inc (NASDAQ:RUN) to "neutral" ...
today announced that management will participate in a fireside chat at the Piper Sandler 36 th Annual Healthcare Conference on Thursday, December 5, 2024, at 9:00 AM Eastern Time. A live audio ...
Piper Sandler's Christopher Raymond joins 'Fast Money' to talk Amgen's stock sinking on GLP-1 results. Kamala Harris ...
Investing.com -- The recent nominations by President-elect Donald Trump, including Matt Gaetz and RFK Jr., are signaling what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback